IP Library Granted Patent US 6,991,925
Granted Patent B2
US 6,991,925 · App. 10/192,454 · Granted Jan 31, 2006

Fermentation of clavulanic acid at a controlled level of ammonia

Assignee: DSM IP Assets B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,991,925
App. No.
10/192,454
Granted
Jan 31, 2006
Kind
B2
Abstract

A method for the production of clavulanic acid by the fermentation of a clavulanic acid producing microorganism at a controlled level of at least 50 mg/l ammonia has been provided for. Under the application of these reaction conditions surprisingly high production levels of clavulanic acid have been obtained.

Claims (12)

1. A method for the production of clavulanic acid comprising regulating the concentration of ammonium ion during fermentation of a clavulanic acid producing microorganism on a suitable medium comprising carbon and nitrogen sources wherein the concentration of ammonium ion is maintained higher than 50 mg/l and below 2500 mg/l by adding continuously, semi-continuously or batchwise at least one source of ammonium ion during fermentation,

recovering the clavulanic acid produced, and

converting the recovered clavulanic acid into a pharmaceutically acceptable salt.

2. The method according to claim 1 , wherein the concentration of ammonium ion is maintained about equal to or higher than 75 mg/l.

3. The method according to claim 2 , wherein the concentration of ammonium ion is maintained about equal to or higher than 100 mg/l.

4. The method according to claim 1 , wherein the at least one source of ammonium ion is ammonium sulfate or urea.

5. The method according to claim 1 , wherein at least one source of ammonium ion is selected from the group consisting of ammonia and ammonium hydroxide, combined with sulfuric acid and optionally sodium hydroxide.

6. The method according to claim 1 , wherein the pH is maintained between 6.5 and 7.5.

7. The method according to claim 1 , wherein the converting step further comprises

converting the recovered clavulanic acid into an amine salt thereof by adding the corresponding amine salt forming compound and reacting said amine clavulanate with a non-toxic pharmaceutically acceptable salt, and

purifying the salt of clavulanic acid.

8. The method of claim 1 , further comprising purifying the recovered clavulanic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2003
From: DSM N.V.
To: DSM IP ASSETS B.V.
Reel/Frame 014634/0415 →
Priority Claims (1)
EP 98203314 · Sep 29, 1998 · regional
Continuity (3)
Continuation 0940598700 · Sep 27, 1999
Provisional Application 6011840700 · Feb 2, 1999
Related Publication 20020187529A1 · Dec 12, 2002